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Abstract
Background: The water channel protein aquaporin-4 (AQP4) is reported to be of possible major importance for
accessory cerebrospinal fluid (CSF) circulation pathways. We hypothesized that changes in AQP4 expression in
specific brain regions correspond to the severity and duration of hydrocephalus.
Methods: Hydrocephalus was induced in adult rats (~8 weeks) by intracisternal kaolin injection and evaluated after
two days, one week and two weeks. Using magnetic resonance imaging (MRI) we quantified lateral ventricular
volume, water diffusion and blood-brain barrier properties in hydrocephalic and control animals. The brains were
analysed for AQP4 density by western blotting and localisation by immunohistochemistry. Double fluorescence
labelling was used to study cell specific origin of AQP4.
Results: Lateral ventricular volume was significantly increased over control at all time points after induction and
the periventricular apparent diffusion coefficient (ADC) value significantly increased after one and two weeks of
hydrocephalus. Relative AQP4 density was significantly decreased in both cortex and periventricular region after
two days and normalized after one week. After two weeks, periventricular AQP4 expression was significantly
increased. Relative periventricular AQP4 density was significantly correlated to lateral ventricular volume. AQP4
immunohistochemical analysis demonstrated the morphological expression pattern of AQP4 in hydrocephalus in
astrocytes and ventricular ependyma. AQP4 co-localized with astrocytic glial fibrillary acidic protein (GFAP) in glia
limitans. In vascular structures, AQP4 co-localized to astroglia but not to microglia or endothelial cells.
Conclusions: AQP4 levels are significantly altered in a time and region dependent manner in kaolin-induced
hydrocephalus. The presented data suggest that AQP4 could play an important neurodefensive role, and may be a
promising future pharmaceutical target in hydrocephalus and CSF disorders.
Background
Hydrocephalus is commonly defined as increased
amount of cerebrospinal fluid (CSF) in a dilated ventri-
cular system, and the pathophysiology of the disease is
therefore strongly correlated to defects in CSF-circula-
tion [1]. Traditionally CSF circulation has been
described in a hydrodynamic perspective. “The classic
bulk flow theory” explains the CSF circulation as a bulk
flow of fluid from the production site at the choroid
plexus, through the ventricular system and into the sub-
arachnoid space (SAS). Here the CSF is finally absorbed
into the superior sagittal sinus through the arachnoid
granulations. The driving force is thought to be a net
positive pressure gradient between the choroid plexus
and the superior sagittal sinus to overcome the resis-
tance in the arachnoid granulations [1]. Several authors
have questioned this theory, and accessory pathways
have been proposed [2-6]. The accessory pathways
involve absorption sites other than the arachnoid granu-
lations, and are thought to consist of both direct absorp-
tion through parenchyma to brain capillaries and
absorption through lymphatic vessels with relation to
cranial nerves [2-6]. It has been suggested that the
accessory pathways predominate in the immature
human brain, and that the traditional arachnoid pathway
develops throughout childhood. The idea of accessory
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pathways has gained new interest through the observa-
tion of relatively high failure rate of neuroendoscopic
ventriculostomy in neonates and infants [5]. Oi and Di
Rocco [5] reviewed the ontogenesis of arachnoid granu-
lations and “CSF Dynamics Maturation Stages” in
human with adult animals and found that mice, rats and
rabbits are comparable with neonates and infants,
underlining the relevance of the present study.
Aquaporins (AQP) are cellular transmembrane pro-
teins with a central pore [7]. This pore is specific to the
passage of water molecules exclusively in the orthodox
aquaporins, while aquaglyceroporins are permeable to
water and other small uncharged molecules such as gly-
cerol, urea and lactate [8,9]. AQP4 is the most abundant
aquaporin of the brain [10,11] being expressed in astro-
cytic processes including their perivascular endfeet and
processes of the glia limitans. AQP4 is also found in the
basolateral membrane of ependymal cells [12-14]. The
location of AQP4 is therefore specific to blood-tissue
and tissue-CSF border, possibly facilitating fast water
transport dependent on osmotic gradients between
those compartments [15-17]. Limited published work in
this field [15,17-19] suggests that the parenchymal CSF
absorption route is highly dependent on AQP4. Expres-
sion levels of AQP4 could possibly influence resolution
of interstitial hydrocephalic edema and drainage of
excess ventricular CSF. In this study we hypothesized
that changes in AQP4 expression in specific brain
regions correspond to the severity and duration of
hydrocephalus. Hence our objective was to study the
spatiotemporal changes in brain AQP4 expression dur-
ing experimental hydrocephalus relative to healthy phy-
siological conditions.
Methods
Ethics and study design
The study was approved by the Danish Animal Experi-
ments Inspectorate (Ministry of Justice, license number
2006/561-1169) and carried out in accordance with both
European and Danish law and legislation for laboratory
animal experiments. Animal welfare was protected by
minimizing animal numbers, pain, suffering, and lasting
harm. We used an experimental kaolin model of hydro-
cephalus in rat compared to a control group. Magnetic
resonance imaging (MRI) was used to describe the
hydrocephalic condition (ventricular size, brain water
diffusion and blood brain barrier (BBB) integrity). For
tissue analysis antibody-based methods (Western blot-
ting (WB), immunohistochemistry (IHC) and immuno-
fluorescence (IF)) were used to investigate AQP4
expression, cellular localization, and quantification dur-
ing hydrocephalus.
The study focused on predetermined regions of inter-
est (ROIs) (Figure 1) to correlate regional AQP4
expression with imaging by using MRI. The aim was to
classify the temporal expression pattern by comparing
the brain AQP4 levels with brain water diffusion and
lateral ventricular volume at 2 days, 1 week, and 2
weeks after the induction of hydrocephalus. As we
wished to study the hydrocephalic condition, three non-
hydrocephalic animals (all belonging to the two week
group) were omitted from the data analysis.
Induction of hydrocephalus
Sprague-Dawley (Tac:SPRD, outbred stock, mean
weight: 293 g, ~8 weeks of age) adult male rats were
anaesthetized with s.c. injection of 0.3 ml/100 g fenta-
nyl/fluanisone/midazolam/atropine mixture (2 ml Hyp-
norm® (fentanyl: 0,315 mg/ml; fluanisone 10 mg/ml), 4
ml midazolam (5 mg/ml), 1.5 ml atropine (1 mg/ml)).
Hydrocephalus was induced in a total of thirty-three
rats through percutaneous injection into the cisterna
magna (25G butterfly needle) of 0.050 ml of sterile kao-
lin suspension (0.250 mg/mL Ringer’s lactate solution
(1.4 mM Ca2+, 4 mM K+, 130 mM Na+, 109 mM Cl-, 28
mM lactate), H:S pharmacy, Copenhagen University
Hospital, Rigshospitalet, Copenhagen, Denmark). The
injection was performed after aspiration of CSF through
the needle, confirming intracisternal access. Our model
had an induction rate of 90% and mortality rate of 9%,
corresponding to recently reported rates [20], and better
than historically reported rates.
The surviving thirty rats were randomized to 3 groups
with different observation periods (2 days (n = 10),
1 week (n = 10), 2 weeks (n = 10)). Eleven control rats
received an injection of 0.050 ml vehicle [21,22], and the
surviving control rats (n = 10) were divided into
approximately equal groups (n = 3/n = 4/n = 3) and
assigned to three groups with the same observation peri-
ods as kaolin-injected animals. All rats were closely
observed throughout recovery from anesthesia, and
housed in a controlled environment (~24°C, ~35%
humidity, 12 h/12 h light/dark schedule) with ad libitum
access to food and water. Prior to MRI investigation the
rats were weighed and scored for general clinical condi-
tion [23,24] daily.
MR-imaging
At the end of the observation period, MR-imaging was
performed using a Varian 4.7T imaging and spectro-
scopy system. The hydrocephalic rats (two days, n = 10;
one week, n = 10; two weeks, n = 10) and the controls
(n = 10) were anaesthetized using fentanyl/fluanisone/
midazolam/atropine mixture (see above). A tail vein was
cannulated and the animal placed inside a home-built 4
cm diameter quadrature head coil. The animal was
secured using a stereotactic device incorporated into the
design of the head coil. For positioning, a midsaggital
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scout was acquired before the three main image
sequences were performed. For lateral ventricular
volume measurements, an optimized T2-weighted fast
spin-echo sequence was used. Twenty-two contiguous
axial slices (TR = 5600 ms, echo train length = 16, effec-
tive TE = 112 ms, NEX = 16, FOV = 35 × 45 mm2,
matrix 256 × 256, slice thickness = 0.5 mm) were
acquired in interleaved order. Image processing software
(MIPAV application, http://mipav.cit.nih.gov) was used
to delineate the lateral ventricles on the twenty-two
slices (Figure 1A, B, C). An approximate value for the
volume of the lateral ventricles was then calculated.
In order to determine the water diffusion properties of
the tissue, a quantitative diffusion imaging sequence was
used. The mid-sagittal scout was used to plan the posi-
tion of the slices, ensuring that the anatomical sampling
in each rat was essentially identical. Twelve contiguous
coronal slices were acquired in interleaved order using
the following parameters: TR = 1500 ms, TE = 65 ms,
FOV = 35 × 35 mm2, matrix = 128 × 128, slice thick-
ness = 1 mm, gradient pulse duration δ = 7 ms, gradient
pulse separation Δ = 50 ms, b-values = 0, 602, 1069,
1671 s/mm2 with the bipolar gradient applied in three
orthogonal directions. Three different ROIs (cortex,
periventricular and periaqueductal) corresponding to
regions predetermined through Paxinos and Watson’s
rat brain atlas [25] were drawn on the b = 0 images
using MIPAV (Figure 1D). The value of the apparent
diffusion coefficient (ADC) for each ROI was calculated
using MatLab® software.
In addition, T1-weighted pre- and post-contrast injec-
tion (0.5 mmol/kg Magnevist (GdDTPA)) spin-echo
images were acquired using the following parameters:
TR = 300 ms, TE = 14 ms, NEX = 4, matrix = 128 ×
128. Slice positioning was identical to the positioning in
the diffusion weighted sequence. BBB integrity was
determined by subtraction of pre-contrast images from
post-contrast images (Figure 1E-G).
Tissue dissection and preparation
Within 1 h after MRI all rats were euthanized by decap-
itation whilst under continued anesthesia. The brain was
removed and cooled for 10 min at 4°C in 0.1 M PBS-
buffer (pH 7.4; 80 mM Na2HPO4, 20 mM NaH2PO4,
100 mM NaCl). The brain was embedded in an acrylic
brain matrix then sliced in 1 mm slices. The four slices
which covered the lateral ventricles and aqueductal area
were separated into two pairs. Tissue samples were dis-
sected from one slice of each pair. The dissected sam-
ples corresponded to the predetermined ROIs (see
above). Samples were frozen in liquid N2 and stored for
WB. The other slice from each pair was immersion-
fixed in 4% formalin solution for 1 h and then stored in
0.1 M PBS-buffer until IHC and IF were performed. The
Figure 1 MRI imaging. A T2-weighted fast spin-echo sequence was used for quantification of lateral ventricular volume (A: control, B: 2W
kaolin). Twenty-two contiguous T2-weighted axial slices were acquired in interleaved order, as shown in C. For quantification of water diffusion,
four different regions of interest (cortex (yellow), periventricular (red), periaqueductal (purple) and CSF (green)) were drawn, using the b = 0
images, and apparent diffusion coefficient values were calculated for each ROI (D). In addition, T1-weighted pre (E) and post (F) contrast images
were acquired. Blood brain barrier integrity was determined by subtraction of pre-contrast images from post-contrast images (G).
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two immersion-fixed slices from each rat were dehy-
drated in increasing ethanol concentrations overnight
and embedded in paraffin wax.
Western blotting
The frozen tissue samples were homogenized on ice in 1
mL of dissection buffer (0.3 M sucrose, 25 mM imida-
zole, 1 mM EDTA) supplemented with protease inhibi-
tors (leupeptin and Pefa-block). The homogenate was
centrifuged at 4000 g for 15 min. The supernatants were
assayed for protein concentration using a bicinchoninic
acid (BCA) protein assay (Thermo Scientific, Pierce Pro-
tein Research Products, Slangerup, Denmark, cat. no.:
23235) in a standard spectrophotometer. Hereafter, pro-
teins were solubilized in sample buffer (50 mM Tris
HCL pH 6.8, 10% glycerol, 6 mg/mL bromophenol blue
and 2.5% sodium dodecyl sulphate, SDS) and the final
gel sample was made by adding 30 μg/ml dithiothreitol
(DTT) and heating the sample at 65°C for 15 min.
Samples were loaded as 15 μg/lane of total protein on
a 12.5% SDS-polyacrylamide gel for electrophoresis (Bio-
Rad Laboratories, Copenhagen, Denmark, 12.5% Tris-
HCL Criterion gel) and were run on a Bio-Rad Criterion
Cell system. Each gel represented a ROI. Samples from
the control group were loaded together with samples
from one of the three kaolin groups. The proteins were
transferred onto a nitrocellulose membrane by electroe-
lution using a Bio-Rad Criterion blotting system. Mem-
branes were blocked for 1 h with 5% skimmed milk in
phosphate-buffered saline with Tween (PBS-T, PBS with
0.1% Tween 20, pH 7.5), washed three times in PBS-T
for 25 min and incubated overnight with following pri-
mary antibodies: rabbit anti-AQP4, diluted 1:1000 (Alo-
mone Labs Ltd., Jerusalem, Israel, cat.no. AQP-004) or
rabbit anti-actin diluted 1:1000 (Sigma-Aldrich,
Brondby, Denmark, cat.no. A2066). The blots were
washed, as above, and incubated at room temperature
for 1 h with horseradish peroxidase (HRP) conjugated
secondary antibody diluted 1:3000 (Dako A/S, Glostrup,
Denmark, cat.no.: P0448). Finally, antibody binding was
visualized using an enhanced chemiluminescence (ECL)
system (Amersham International, GE Healthcare Europe
GmbH, Brondby, Denmark).
Immunohistochemistry
The paraffin-embedded brain tissue slices were cut into
serial 6 μm thick frontal sections, which were dewaxed
and rehydrated according to standard methods. All sec-
tions were incubated in 0.5% H2O2 in Tris-buffered sal-
ine (TBS)/Nonidet (Sigma-Aldrich, cat. no.: N-6507) for
30 min at room temperature to quench endogenous per-
oxidase. Sections were incubated with 10% normal goat
serum (In Vitro, Fredensborg, Denmark, cat. no.: 04009-
1B) in TBS/Nonidet for 30 min at room temperature in
order to block non-specific binding. Incubation with pri-
mary antibodies was performed overnight at 4°C with
rabbit anti-AQP4 diluted 1:200 (Alomone Labs Ltd., cat.
no.: AQP-004). The primary antibodies were detected by
using biotinylated goat anti-rabbit IgG diluted 1:400
(Sigma-Aldrich, cat. no.: 3275) for 30 min at room tem-
perature followed by streptavidin-biotin-peroxidase com-
plex (StreptABComplex/HRP, DAKO, DK, cat. no.:
K377) prepared at manufacturer’s recommended dilu-
tions for 30 min at room temperature. The immunor-
eaction was visualized using 0.015% H2O2 in 3,3-
diaminobenzidine-tetrahydrochloride (DAB) as chromo-
gen for 10 min at room temperature. As negative
controls, we performed IHC after above mentioned pro-
tocol, omitting either primary or secondary antibodies
in parallel to standard procedure.
Immunofluorescence
The AQP4 expressing cell types were characterized by
using double fluorescence staining for AQP4 and cell
type markers: glial fibrillary acidic protein (GFAP) for
astrocytes and tomato lectin for endothelium and micro-
glia. Sections from five rats in each group were incu-
bated overnight with rabbit anti-AQP4 (as above)
simultaneously with rat anti-GFAP diluted 1:100 (InVi-
trogen, Taastrup, Denmark, cat. no.: 13-0300) or fluores-
cein labeled lycopersicon esculentum (tomato) lectin
(Vector/VWR, Rodovre, Denmark, cat. no.: FL-1171)
diluted 1:50. The primary anti-AQP4 antibodies were
detected by using goat anti-rabbit IgG 1:50 linked with
Texas red (TxRED) (Southern Biotech, Birmingham,
USA, cat. no.: 4050-07), while the anti-GFAP antibodies
were detected by using goat anti-rat IgG linked with
fluorescein isothiocyanate (FITC) (Calbiochem, The
Merck Group, Nottingham, United Kingdom, cat.no.:
401414) for 30 min at room temperature. Finally, sec-
tions were incubated with 4’,6-diamidino-2-phenylindole
(DAPI) (Invitrogen, cat.no.: D1306) for 5 min in order
to obtain a nuclear counterstaining. Sections were
embedded in anti-fading mounting medium and kept in
darkness at -20°C. A Zeiss Axioplan2 light microscope
equipped with a triple band (FITC/TxRED/AMCA) filter
was used for the examination and recording of the
stained specimens.
Quantification, analysis and statistics
Densitometry of ECL films was performed using Quanti-
tyOne software (Bio-Rad Laboratories). Equal total load-
ing of protein was further confirmed by densitometry of
the actin signal. Finally AQP4 density was normalized
against the b-actin signal.
A twin Zeiss AxioImager A.1 light microscope with a
40× (NA 0.75) objective was used for the examination of
the IHC stained specimens. The tissue sections were
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described in parallel by two observers (ADS and MJ). The
upper lateral wall of the lateral ventricle 2-3 mm posterior
to Bregma [25] was chosen for our description of the mor-
phological staining pattern. Before examination, the slides
were blinded by an independent colleague. Blinding was
removed after examination of all slides.
IF-stained sections (five from each group) were ana-
lysed qualitatively regarding co-localisation of GFAP and
AQP4, and AQP4 expression in relation to lectin stain-
ing, blinded by one observer (ADS).
Data from three non-hydrocephalic animals (all
belonging to the two week group) were omitted from
the data analysis. Quantitative data from WB and MRI
were analysed by calculating median, interquartile range
and total range and presented as box plots. Plotting of
frequency distribution with and without transformation
did not meet the assumption of a normal distribution.
Therefore non-parametric testing was used. Significance
between groups was determined using the Kruskal-
Wallis’ test including post test to compare relevant
groups. Results from statistics are presented as median
(interquartile range), significance level p = 0.05. Plot and
statistical analyses were performed using the GraphPad
Prism Software Package (version 4.03). As we required
that the raw data obtained from all three methods (WB,
IHC, IF) were of sufficient quality for reliable data ana-
lysis, some samples had to be omitted from each techni-




Quantification of lateral ventricular volume by in vivo
MRI showed failed induction of hydrocephalus in three
animals belonging to the two-week group. Consequently,
these animals were not analysed resulting in the two-
week group consisting of only seven rats. When com-
pared to the lateral ventricles of control animals which
was 5.0 mm3 (4.0-7.5, median and interquartile range),
significantly enlarged lateral ventricles were observed in
hydrocephalic rats at two days, 34.5 mm3 (19.5-37.5),
p < 0.01; one week, 39.5 mm3 (25.0-76.0) p < 0.001; and
at two weeks, 91.0 mm3 (58.0-123.0) p < 0.001). Results
are summarized in Figure 2.
Apparent diffusion coefficient
ADC values were calculated for each of the ROIs and
the results are presented in Figure 3. Significant differ-
ences occurred in the periventricular ROI between the
ADC values of control and both one-week and two-
week groups (Kruskal-Wallis, p < 0.05) but not in the
2-day group. Control: 75.5*10-5mm2/s (70.4-83.2);
two days: 84.3*10-5mm2/s (81.6-90.4); one week:
88.1*10-5mm2/s (83.0-99.1); two weeks 89.1*10-5mm2/s
(85.9-90.3). No significant differences between control
and any group of hydrocephalic rats were observed in
the other regions.
BBB integrity
The integrity of the BBB was assessed by image subtrac-
tion of pre- from post-contrast T1-weighted images (Fig-
ure 1E, F, G). Qualitative description showed no signal
enhancement besides the expected vessel enhancement.
This confirmed preserved BBB integrity in all cases.
AQP4 expression
Western Blotting
Western blotting revealed an immunoreactivity signal at
~42 kD corresponding to b-actin, and ~30-32 kD
Figure 2 Lateral ventricular volume . Quantitative MRI data,
presented as box plot (median, interquartiles and range, n = 10 for
all groups except 2W when n = 7). In each group the median and
interquartile range were as follows (Kruskal-Wallis), control: 5.0 mm3
(4.0-7.5); two days (2D): 34.5 mm3 (19.5-37.5); one week (1W): 39.5
mm3 (25.0-76.0); two weeks (2W): 91.0 mm3 (58.0-123.0). The
hydrocephalic groups had significantly larger ventricles, p < 0.01,
0.001 and 0.001 at 2 D, 1W and 2W, respectively.
Figure 3 Apparent diffusion coefficient (ADC) values. Box plot
showing each region of interest in each group (control and 2-day,
1-week and 2-weeks hydrocephalus) quantified by MRI (median,
interquartiles and range, n = 10 for all groups except 2W when n =
7). Periventricular ADC values showed a significant difference
(Kruskal-Wallis) between the control group and both the one week
and two week group, p < 0.05 for both. Control: 75.5*10-5mm2/s
(70.4-83.2; two days: 84.3*10-5mm2/s (81.6-90.4); one week: 88.1*10-
5mm2/s (83.0-99.1); two weeks 89.1*10-5mm2/s (85.9-90.3). No
significant differences were found between groups in any other
regions of interest.
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corresponding to AQP4 (Figure 4). AQP4 expression
was significantly decreased (Kruskal-Wallis) relative to
control in both the periventricular region after two days
of hydrocephalus (control: 1.00, 0.95-1.04, two day: 0.78,
0.63-0.084, p < 0.05) and in the cortex (control: 1.00,
0.93-1.14, two day: 0.81, 0.67-0.97, p < 0.05) and nor-
malized after one week. After two weeks significantly
increased periventricular AQP4 expression was observed
(control: 1.00, 0.88-1.2; two weeks: 1.40, 1.27-1.64, p <
0.05). No change in AQP4 expression was found in the
periaqueductal region at any time.
Immunohistochemistry
Intraparenchymal AQP4 immunoreactivity in the peri-
ventricular region consistently showed a reticular
staining pattern indicating that AQP4 reactivity
occurred in glial processes (Figure 5). The continuous
glial reticular pattern seemed to diminish in the acute (2
days) and subacute (1 week) phases of hydrocephalus
and re-appear in the later stages (2 weeks), possibly
reflecting the time-dependent quantitative changes
observed by WB. Immunoreactivity of the ependyma
showed a cuboidal pattern in all controls appearing
either single- or multilayered [26]. In hydrocephalic ani-
mals, the ependymal pattern was disrupted in several
cases; particularly in the 2-week group. In this group,
several types of ependymal changes could be seen
including loss of ependymal staining, flattening or a
relative loss of multilayering (Figure 6).
Figure 4 Aquaporin-4 western blotting. Immunoreactivity signal at ~42 kD corresponds to b-actin, and ~30-32 kD corresponds to aquaporin-
4. Western blots from the periventricular region of interest are shown as example. Two of the periventricular samples (one control and one two
day) did not meet the minimum total protein level for western blotting, and therefore data from these two rats could not be obtained.
Densitometry of ECL films was performed using QuantityOne software (Bio-Rad Laboratories). Aquaporin-4 signal was normalized against the
b-actin signal. Relative aquaporin-4 expression values for each ROI are presented as box plots (median, interquartile range and total range). At
day two a significant (Kruskal-Wallis) decrease compared to control in aquaporin-4 expression was found in both periventricular region (control:
1.00, 0.95-1.04, two day: 0.78, 0.63-0.084, p < 0.05) and cortex (control: 1.00, 0.93-1.14, two day: 0.81, 0.67-0.97, p < 0.05). Expression was
normalized after one week, but after two weeks we found significantly increased periventricular expression (control: 1.00, 0.88-1.21; two weeks:
1.40, 1.27-1.64, p < 0.05). No significant changes were found in the periaqueductal region.
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No difference in AQP4 immunoreactivity of glia limit-
ans or in the periaqueductal region was identified in
hydrocephalic groups compared to controls. No AQP4
immunoreactivity of choroid plexus was seen. The speci-
ficity of the immune reaction was confirmed by the pre-
sence of perivascular “vessel-like” staining identified in
all cases by the negative control sections, which were
devoid of AQP4 immunostaining.
Double fluorescence staining
Fluorescence staining for AQP4 and GFAP or lectin
revealed that astroglia are the main source of AQP4
expression in the brain, while endothelial cells and
microglia are devoid of AQP4 expression (Figure 7 and
Figure 8). Double IF for AQP4 and GFAP showed co-
localisation both in control and hydrocephalic groups at
all time points, in which AQP4 was observed in the
astroglial endfeet surrounding the vessels and in glia
limitans (Figure 7). Combined AQP4 IF and lectin fluor-
escence staining in both controls and hydrocephalic rats
showed complementary immunoreactivity, clearly not
co-localized in glia limitans or in endothelial cells (Fig-
ure 8). In both controls and hydrocephalic rats microglia
stained by lectin did not express AQP4. Lectin in all
cases intensively stained the apical membrane of the
Figure 5 Immunohistochemistry of aquaporin-4 in the periventricular region. A: low magnification picture representing a control rat. The
boxed area shows the studied periventricular region. B and C: different patterns of aquaporin-4 immunoreactivity. Aquaporin-4 positive glial
processes were identified as reticular pattern and perivascular “vessel-like” structures. “Vessel-like” immunoreactivity was identified either as
strongly labeled round/eliptical structures where we expect a vessel is cut across (B, arrow) or as parallel lines with branches where a vessel is
cut in its length direction (C, arrow). “Vessel-like” immunoractivity was identified in all cases. The reticular pattern could further be categorized as
either continuous (B) or discontinuous (C). In cases of discontinuous reticular pattern, larger areas were found devoid of the reticular pattern. In
controls the continuous pattern prevailed, in the acute phase (two day and one week) a trend pointed towards the discontinuous pattern, and
finally at 2 weeks the reticular pattern was again prominent. The inserted table summarizes the proportion of rats in each group presenting
either continuous or discontinuous reticular pattern and the proportion of rats showing perivascular “vessel-like” immunoreactivity. This suggests
a dynamic response in the expression pattern of aquaporin-4. No evidence of immunoreactivity in cell soma of astrocytes was found. Negative
immunohistochemistry controls did not show any immunoreactivity. * = lateral ventricle. A scale bar 100 μm; B and C scale bar 50 μm.
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Figure 6 Aquaporin-4 immunohistochemistry of the ependyma. The aquaporin-4 positive ependymal cell lining of each rat was categorized
as belonging to one of four different aquaporin-4 immunoreactivity morphologies (single-layered cuboidal (A), multilayered cuboidal (B), no
staining (C) and flattened ependyma (D)). The table shows the proportion of animals in each group belonging to each morphological category.
Cuboidal ependyma in single- or multilayered patterns were found in all groups. In the two day group, two cases were found to have lost
ependymal staining. At two weeks a diversity of morphologies were reported ranging from single layered cuboidal to flattened in the case of
most extreme hydrocephalus. No clear evidence of apical expression of aquaporin-4 in ependymal cells was found at any time point. Scale bar
50 μm.
Figure 7 Double immunofluorescence for aquaporin-4 and glial fibrillary acidic protein in control and two week hydrocephalic rat.
Aquaporin-4 is visualized with TxRED (red) and glial fibrillary acidic protein with FITC (green). Nuclear counterstaining with DAPI (blue). Pictures
represent glia limitans (A-F), periventricular region (including ependyma) (G-L) and vessels (M-R). Yellow colours in merged pictures confirm co-
localization of aquaporins-4 and astrocytic GFAP in glia limitans and in perivascular endfeet. Both in control and in all hydrocephalic groups
aquaporin-4 and glial fibrillary acidic protein showed co-localisation in the astroglial endfeet surrounding the vessels (M-R) and in glia limitans
(A-F). Astrocytic cell soma were mainly without evidence of aquaporin-4 expression. * = lateral ventricle. Scale bar 100 μm.
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ependymal cells. Immunoreactivity of AQP4 both in
controls and hydrocephalic rats localised to the basolat-
eral membrane of the ependymal cells lining the ventri-
cular wall, thus confirming conserved polarisation of the
AQP4 positive ependymal cells in hydrocephalus.
Correlation between periventricular AQP4 expression and
quantitative MRI
In order to test the hypothesis that AQP4 expression
could be related to severity of hydrocephalus, we per-
formed linear regression analysis of AQP4 expression
relative to median of control group against lateral ven-
tricular volume across all groups (Figure 9). We found a
significant linear positive correlation between lateral
ventricular volume and periventricular AQP4 expression
(r2 = 0.33, p = 0.002) in hydrocephalic animals. No sig-
nificant linear correlation between periventricular AQP4
expression and ADC value was found (Figure 9).
Discussion
The present study shows regional- and time-dependent
regulation of AQP4 expression in experimental hydroce-
phalus. In summary, AQP4 abundance was found signif-
icantly decreased relative to control in both the
periventricular region and in the cortex after two days
of hydrocephalus and normalized after one week. After
Figure 8 Combined aquaporin-4 immunofluorescence and flouorescein linked lectin staining in control and two week hydrocephalic
rat. Aquaporin-4 visualized with TxRED (red) and lectin with FITC (green). Nuclear counterstaining with DAPI (blue). Pictures represent glia
limitans (A-F), ependyma (G-L) and vessels (M-R). In both contol and hydrocephalic rats aquaporin-4 and lectin staining showed complementary
immunoreactivity, clearly not co-localized in glia limitans (A-F). In the ependyma lectin intensively stained the apical membrane of the cells
bordering the ventricular wall (H, I, K, L). Immunoreactivity of aquaporin-4 in controls clearly localised to the basolateral membrane (G). In
hydrocephalic animals presenting changed aquaporin-4 morphology of the ependyma (J-L), the aquaporin-4 immunoreactivity of the cells lining
the ventricle was found not to co-localize with the continuous apical staining of the ependymal cells by lectin (K), except in specific areas
corresponding to the lateral membrane of the ependymal cells (arrows, K). This confirmed basolateral expression of aquaporin-4 in the
ependymal cells of hydrocephalic rats. In vessels (M-R) aquaporin-4 was clearly located to perivascular areas without signs of endothelial
expression. No evidence of aquaporin-4 expression in microglia was found; neither in controls nor in hydrocephalic rats. * = lateral ventricle.
Scale bar 50 μm.
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two weeks of hydrocephalus significantly increased peri-
ventricular AQP4 expression was observed. The changes
in AQP4 expression coincided with significantly
increased periventricular ADC value after one and two
weeks of hydrocephalus, but no direct linear correlation
was found. Double fluorescence staining confirmed the
cell-specific expression of AQP4 and did not provide
any evidence of endothelial AQP4 expression in hydro-
cephalus. Previously, only a few studies have investigated
AQP4 expression in hydrocephalus (recently reviewed
by Owler et al [27] and Filippidis et al [28]). In a hydro-
cephalus model in adult rats induced by L-a-lysopho-
sphatidylcholine stearoyl (LPS), ventriculomegaly was
correlated to increased AQP4 in astrocytes residing in
periventricular areas such as in corpus callosum [17]. In
kaolin-mediated severe hydrocephalus in neonatal (one-
day old) and juvenile (three weeks old) rats, an intense
cerebral, perivascular AQP4 immunostaining was
reported at four weeks and nine months post-injection
in the juvenile animals, although the study did not find
significant AQP4 changes by using WB [18]. However,
the finding of AQP4 immunoreactivity in perivascular
astrocytes in LPS-induced hydrocephalus [17] support
the data presented in this study showing time-dependent
AQP4 changes following kaolin injection. The observed
increase in AQP4 levels seen at 2 weeks in this study
are likely due to de novo AQP4 synthesis, as AQP4
mRNA is significantly upregulated in hydrocephalic rat
brains [18]. In an experimental study of congenital
hydrocephalus [19] using the H-Tx rat [29] it was sug-
gested that AQP4 could be important for developing
alternative CSF-absorption pathways [16].
The functional significance of AQP4 during hydrocepha-
lus has previously been investigated by using AQP4-null
mice that show accelerated progression of ventriculome-
galy relative to wild type controls [15]. This suggests that
cerebral AQP4 is neuroprotective and accordingly, the
increase in AQP4 expression as presented here might
represent a host defense mechanism against kaolin-
mediated pathology. A similar role of AQP4 is reported in
a bacterial brain abscess coupled with vasogenic edema, in
which AQP4-deficient mice show significantly higher ICP,
brain swelling, and cerebral water content than their wild
type controls [30]. Also, in 3 different models of brain
edema such as a freeze-injury model of cerebral vasogenic
edema [31], a brain tumor model of edema [31] and a
model of edema following subarachnoid haemorrhage
(SAH) [32], AQP4-deficient mice displayed increased CNS
water accumulation, deteriorated neurological outcome
and increased ICP when compared to those of wild type
control mice [31-33]. Hydrocephalic edema however
represents water accumulation different from both vaso-
genic and cytotoxic edema, because of the absence of BBB
disruption and cell swelling. A model of continuous intra-
cerebral fluid infusion mimicking purely interstitial edema
showed a poorer outcome in AQP4-null mice [31]. AQP4
deficient animals thus have a poorer outcome in condi-
tions with both vasogenic and interstitial (hydrocephalic)
edema. All these data indicate a role for AQP4 in the cere-
bral resolution of an established edema, in which the
mechanisms likely involve astroglial clearance of excess
brain water by transcellular routes and/or through the glia
limitans. However, contrasting data are found in studies of
other CNS disease models (such as ischemia, meningitis
and trauma), in which AQP4-null mice display a better
outcome, in terms of neurological score and brain water
content, than wild type controls [34-36]. These studies
indicate that altered AQP4 expression is rate-limiting for
brain water transport and edema implying that altered
AQP4 expression maybe functionally significant in cases of
disturbed CSF circulation. Specifically, the results obtained
in AQP4-deficient mice along with our data suggest that
the dual regulation of AQP4 could serve as a
Figure 9 Correlation between quantitative MRI and relative
AQP4 expression. Plots of lateral ventricular volume vs. relative
aquaporin-4 expression (A) and periventricular apparent diffusion
coefficient value vs. relative aquaporin-4 expression (B) in both
controls, hydrocephalic (two days, 2 D, one week,1W and two
weeks, 2W) and non-hydrocephalic kaolin-injected animals. In
hydrocephalic animals we found a significant linear positive
correlation between lateral ventricular volume and periventricular
aquaporin-4 expression (r2 = 0.33, p = 0.002). No correlation
between periventricular apparent diffusion coefficient value and
relative aquaporin-4 expression was found.
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compensatory host defense response to obstructive hydro-
cephalus. We therefore suggest a biphasic neuroprotective
response consisting of down-regulation of AQP4 after two
days, corresponding to acutely increased ICP, and up-regu-
lation after two weeks, corresponding to a near-normal
ICP phase [15,37-40]. The phenotypic and pathological
analyses of AQP4-modulated mice indicate a role for
AQP4 in cerebral bidirectional water transport and edemal
pathophysiology. As discussed here, cerebral AQP4 might
exert a paradoxic role contributing to cytotoxic/cellular
edema while protecting against vasogenic/interstitial
edema in the brain. Thus, AQP4 inhibition or antagonism
of its signalling, potentially reduce the development of
cytotoxic edema by means of reducing cellular water accu-
mulation in the brain. In contrast, AQP4 mimetics or
inducers of AQP4 expression in astroglia can likely remove
excess brain water from the extracellular compartment
thereby facilitating the resolution of vasogenic/interstitial
edema. However, the molecular mechanisms of actions
and/or the signalling pathways involved in the differential
effects of AQP4 in the intracellular versus extracellular
space, respectively, remain to be elucidated. Yet, current
data support the notion of AQP4 exerting such dual roles
that likely are functionally separated by means of the spa-
tial compartment (inside vs. outside cells) and differential
molecular surroundings found in the extracellular vs. intra-
cellular space. Supporting this notion, potassium dynamics
within cerebral extracellular matrix and the brain’s extra-
cellular tissue volume are closely associated to AQP4 pro-
tein levels [41,42]. We hypothesize that pharmaceutical
regulation of AQP4 may be used in the future to manage
the clinical course and neurological outcome of hydroce-
phalus. The potential effects of pharmacological interven-
tion may not be limited to the water transport role of
AQP4 since recent research suggests additional functions.
Evidence from in vitro studies propose that AQP4 acts as a
cell adhesion molecule [43,44], maintains ependymal integ-
rity [45] and plays a significant role in adult neurogenesis
[46,47]. One study [48] connected the different functions
of AQP4 to hydrocephalus by reporting a 9.6% rate of
sporadic obstructive hydrocephalus as consequence of dis-
organised ependyma and aqueductal stenosis in AQP4-null
mice. Whilst our data also suggest disorganisation of the
ependyma as well as changes in AQP4 expression, our
study design does not allow us to address any specific cor-
relation. Further studies therefore need to consider that
pharmacological regulation of AQP4 may influence hydro-
cephalus in different ways.
Our data confirm astrocytic and ependymal cell locali-
zation of AQP4 in both normal brain and in hydroce-
phalic brain pathology. AQP4 co-localizes with
astrocytic GFAP in both glia limitans and perivascular
end feet. These results support original studies by IHC
and high-resolution electron microscopy on cellular
domains expressing AQP4 in rat brain under normal
conditions [10,14,49]. The studies revealed polarised
expression of AQP4 under normal physiological condi-
tions. AQP4 was restricted to glial cells with morpholo-
gic features typical of astrocytes and ependymal cells.
The most distinct expression was found in glial mem-
branes facing capillaries and pia mater [10,14,49]. We
saw no evidence of apical AQP4 expression in ependy-
mal cells at any time point, providing no evidence for
the “missing step” in water transport across the ependy-
mal cell membrane. By double fluorescence combining
AQP4 and lectin staining, we found no evidence of
AQP4 expression in microglia. In contrast AQP4 mRNA
and protein has been reported in reactive OX-6 positive
microglia after LPS injection [50]. No evidence for neu-
ronal expression of AQP4 currently exists [10,14,51,52].
In vascular structures, AQP4 co-localized to astroglia
but not to endothelial cells. One study [53] arguments
for endothelial expression of AQP4 mRNA and protein
in preparations of rat cerebral microvessels. This con-
trasts to our and other’s previous data [14]. It is possi-
ble, as the authors suggest themselves, that the
preparations were contaminated with glial membranes.
Thus, our data do not suggest changed cell type expres-
sion of AQP4 in hydrocephalus, but rather changed
level of the constitutive expression.
Our observation of decreased abundance of AQP4 in the
periventricular region after two days of hydrocephalus
coincide with symptoms indicative of raised intracranial
pressure (ICP) as judged by clinical symptoms. This is
further supported by the time course of ICP in kaolin-
mediated hydrocephalus, where an acute rise in ICP is
seen within one day followed by a markedly elevated but
stationary ICP that after several weeks ultimately
approached a near-normal level [15,37-40]. Together with
the acute decreased abundance of AQP4 in the periventri-
cular region we found normal ADC-values in the same
region. At two weeks, increased abundance of AQP4
expressed in astrocyte processes of the periventricular
region was found, together with significant elevated ADC
values. Linear regression did not propose direct linear cor-
relation of ADC values and AQP4 expression in the peri-
ventricular region, in opposition to data presented in one
other study [17]. We consider that changes in ADC values
and AQP4 represent phases of ICP changes following
hydrocephalus development. Other authors present similar
initially non-significant decreases in periventricular white
matter ADC values one day after kaolin injection followed
by significant increases in periventricular ADC at eight
days [54]. Caution should be taken when interpreting
ADC values. By using diffusion weighted MRI and calcu-
lating ADC values it is possible to identify acute CNS
injury following e.g. ischemia and status epilepticus
[54-56]. It has been proposed that decreased ADC values
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may result from cell swelling, loss of extracellular volume
and reduction in transmembrane water movement [54]. In
the same study it was shown that cell injury following glo-
bal ischemia causes decreased ADC values in both extra-
and intracellular compartments [54]. Therefore, ADC
value alone cannot distinguish between intracellular and
extracellular edema. In hydrocephalus the periventricular
extracellular volume is increased either by direct passage
of CSF from the lateral ventricles or by stagnant periven-
tricular fluid generated from brain tissue [57]. We believe
that the changes in ADC values observed in this study are
indicative of extracellular edema. The missing correlation
between AQP4 expression and ADC-values indicate that
other factors such as co-transporters may play a major
role in brain water transport.
Conclusions
This study provides evidence of significant variation in
the temporal and spatial regulation of AQP4 in the kao-
lin-induced hydrocephalic rat brain. Novel data confirm
a dynamic response consisting of significantly decreased
abundance of AQP4 in the periventricular region and
cortex at two days and significantly increased periventri-
cular abundance of AQP4 after two weeks of hydroce-
phalus. In addition we present data confirming an
astrocytic and ependymal origin of AQP4 expression
during hydrocephalic brain pathology. ADC values show
the presence of periventricular interstitial edema at one
and two weeks of hydrocephalus. In the light of the
putative differential roles of AQP4 discussed in this
study, this could point towards a role for AQP4 as a
drug target with the potential to be clinically exploited.
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